| Medical Science Liaison Allergy / Derm MN, WI, ND, SD Remote |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Research & Development |
25. April 2024 |
| Medical Science Liaison (MSL) Neuroscience Eastern PA, Northern NJ |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Research & Development |
17. Oktober 2024 |
| Medical Science Liaison (MSL) ONC Solid Tumor Chicago Territory Remote |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Research & Development |
17. Oktober 2024 |
| Medical Science Liaison Onc Prostate Radioligand Therapies Michigan Territory |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Research & Development |
09. Oktober 2024 |
| Associate Medical Director-RLT |
Remote Position (USA) |
USA |
US |
Innovative Medicines |
Research & Development |
24. Oktober 2024 |
| Medical Science Liaison Onc Prostate Radioligand Therapies DFW or North |
Remote |
USA |
US |
Innovative Medicines |
Research & Development |
05. Juni 2024 |
| Senior Medical Information Manager 2 |
Dublin (Novartis Corporate Center (NOCC)) |
Irland |
Operations |
CTS |
Research & Development |
23. April 2024 |
| Senior Specialist - Automation Engineer |
Sasayama |
Japan |
Operations |
|
Research & Development |
16. Juli 2024 |
| Clinical Project Manager |
Hyderabad (Office) |
Indien |
Operations |
CTS |
Research & Development |
03. September 2024 |
| Sr. Automation Engineer |
Carlsbad |
USA |
Operations |
CTS |
Research & Development |
02. August 2024 |
| Team Lead Medical Communications (Scientific Engagements) |
Dublin (Novartis Corporate Center (NOCC)) |
Irland |
Operations |
CTS |
Research & Development |
09. Oktober 2024 |
| Principal RWE Research Analyst |
Hyderabad (Office) |
Indien |
Operations |
CTS |
Research & Development |
14. Mai 2024 |
| Principal Scientific Writer |
Hyderabad (Office) |
Indien |
Operations |
CTS |
Research & Development |
03. September 2024 |
| Clinical Laboratory Scientist, Generalist |
Carlsbad |
USA |
Operations |
Innovative Medicines |
Research & Development |
17. Mai 2024 |
| Principal RWE Research Analyst |
Hyderabad (Office) |
Indien |
Operations |
CTS |
Research & Development |
06. Juni 2024 |
| Medical Content Lead (m/w/d), Hematology |
Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) |
Deutschland |
International |
Innovative Medicines |
Research & Development |
09. September 2024 |
| Project Team Coordinator (Medical) (m/w/d) |
Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) |
Deutschland |
International |
Innovative Medicines |
Research & Development |
15. Oktober 2024 |
| Medical Scientific Liaison Manager, Immunologie (w/m/d), Gebiet: Sachsen |
Saxony (with Corpus Christi) (Novartis Pharma GmbH) |
Deutschland |
International |
Innovative Medicines |
Research & Development |
18. Oktober 2024 |
| Medical Affairs Lead (m/w/d), Solid Tumors |
Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) |
Deutschland |
International |
Innovative Medicines |
Research & Development |
06. September 2024 |
| Medical Science Liaison Lead |
Warsaw |
Polen |
International |
Innovative Medicines |
Research & Development |
18. April 2024 |
| MSL Manager, RLT |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Research & Development |
18. April 2024 |
| Senior Lead, TA Medical(General Medicines) |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
27. Mai 2024 |
| Lead, Medical Excellence |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
02. Juli 2024 |
| Lead, RWE and Evidence Excellence |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
10. Juli 2024 |
| Associate/Manager, MSL(Oncology) |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
22. Juli 2024 |
| Associate/Manager, MSL (Cardiovascular) |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
20. August 2024 |
| Medical Field Trainer |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
29. August 2024 |
| Group Manager, MSL |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
05. September 2024 |
| Medical Science Liaison - Solid Tumors |
Bucuresti |
Rumänien |
International |
Innovative Medicines |
Research & Development |
17. Oktober 2024 |
| Medical Advisor, Ophtha |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Research & Development |
18. Oktober 2024 |
| Medical Advisor, HEMA |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Research & Development |
18. Oktober 2024 |
| Medical Scientific Liaison |
İstanbul Kavacık |
Türkei |
International |
Innovative Medicines |
Research & Development |
26. September 2024 |
| Associate, TA Medical (General Medicines) |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
07. Oktober 2024 |
| Chef, Éducation médicale - Cancer du sein |
Montreal |
Kanada |
International |
Innovative Medicines |
Research & Development |
18. Oktober 2024 |
| Liaison en sciences médicales - Cancer du sein |
Field Non-Sales (Canada) |
Kanada |
International |
Innovative Medicines |
Research & Development |
23. Oktober 2024 |
| Liaison en sciences médicales - Rheumatologie - Ontario |
Field Non-Sales (Canada) |
Kanada |
International |
Innovative Medicines |
Research & Development |
25. Oktober 2024 |
| MSL Tumeurs Solides - Nord Est |
Field Non-Sales (France) |
Frankreich |
International |
Innovative Medicines |
Research & Development |
29. April 2024 |
| Medical Head Radioligand Therapy |
Rueil-Malmaison |
Frankreich |
International |
Innovative Medicines |
Research & Development |
02. Juni 2024 |
| RWE Lead H/F CDD 12 mois |
Paris Headquarter (Novartis Pharma S.A.S.) |
Frankreich |
International |
Innovative Medicines |
Research & Development |
04. Oktober 2024 |
| Medical Lead |
Copenhagen |
Dänemark |
International |
Innovative Medicines |
Research & Development |
14. Oktober 2024 |
| QC Senior Scientist |
Ivrea |
Italien |
International |
Innovative Medicines |
Research & Development |
14. Oktober 2024 |
| (Senior) Medical Advisor (Radioligand Therapy) |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Research & Development |
09. Oktober 2024 |
| Medical Science Liaison Immunology |
Field Force (England / Wales) |
Vereinigtes Königreich |
International |
Innovative Medicines |
Research & Development |
10. Oktober 2024 |
| Patient Advocacy Manager |
Prague |
Tschechische Republik |
International |
Innovative Medicines |
Research & Development |
10. Oktober 2024 |
| Patient Advocacy & Medical Lead |
Prague |
Tschechische Republik |
International |
Innovative Medicines |
Research & Development |
10. Oktober 2024 |
| Medical Affairs Lead Specialty |
Warsaw |
Polen |
International |
Innovative Medicines |
Research & Development |
11. Oktober 2024 |
| Pipeline Medical Manager CRM |
London (The Westworks) |
Vereinigtes Königreich |
International |
Innovative Medicines |
Research & Development |
11. Oktober 2024 |
| Medical Content Lead Immunologie (m/w/d) |
Munich (Non-Sales Force) (Novartis Pharma GmbH) |
Deutschland |
International |
Innovative Medicines |
Research & Development |
25. Oktober 2024 |
| Medical Science Liaison (MSL), Czech Republic |
Prague |
Tschechische Republik |
International |
Innovative Medicines |
Research & Development |
27. September 2024 |
| Medical Science Liaison, Immunology |
Chongqing (Chongqing Province) |
China |
International |
Innovative Medicines |
Research & Development |
30. September 2024 |